Real-time enrollment status for this hemoglobinopathy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:27 AM UTC
| NCT Number | NCT07373639 |
| Recruiting Status | Recruiting |
| Condition | Hemoglobinopathy |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Beam Therapeutics Inc. |
| Last Updated on CT.gov | January 28, 2026 (Jan 28, 2026) |
As of July 13, 2026: Clinical trial NCT07373639 is currently recruiting participants. This clinical trial study for hemoglobinopathy is actively seeking new participants at 17 locations across the United States. The study is sponsored by Beam Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07373639 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07373639 was last updated Jan 28, 2026 (January 28, 2026). HelloStudys verifies this status automatically.